Indications - Jakavi
Myelofibrosis (MF) Jakavi is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera...
- Twitter Linkedin Facebook Pinterest Google plus
Efficacy
Indication
Safety Profile
Reimbursement
Dosing
Xolair®: Refund first claim (A) (French)
Download French document To receive by post, click on the "Add to card" button belowXolair® CRSwNP - reimbursement extension annex C (French)
Download French document .field-name-field-np4-expiry-date {display:none;} To receive by post, click on the "Add to card" button belowXolair® CRSwNP - initial reimbursement request annex B (French)
Download French document .field-name-field-np4-expiry-date {display:none;} To receive by post, click on the "Add to card" button belowXolair® CRSwNP - initial reimbursement request annex A (French)
Download French document .field-name-field-np4-expiry-date {display:none;} To receive by post, click on the "Add to card" button below